Enavate Sciences GP, LLC

3 filings 2 distinct issuers Active 2025-09-15 → 2026-08-19

Track Record

Total filings

1 SCHEDULE 13D/A · 2 SCHEDULE

Distinct issuers

67% issuer diversity

Median stake

6.77%

3,650,122 avg shares

AI briefs cached

0/3

intent-classified filings

Backtested Performance · post-filing returns (split + dividend adjusted)

Median 30d

+15.1%

across 2 filings · win rate 50%

Median 60d

+24.8%

across 2 filings · win rate 50%

Median 90d

+52.9%

across 2 filings · win rate 50%

Median 1y

—

across 0 filings · win rate —

Anchor: closest trading day on/after filing's date_of_event. Source: Yahoo Finance daily adj_close. Past performance is not indicative of future results.

Filings · 3 total

Filed	Form	Issuer	Stake	Shares
2026-08-19	SCHEDULE 13D/A	Zenas BioPharma, Inc.ZBIO	4.90%	3,245,404	view →
2025-10-14	SCHEDULE	Zenas BioPharma, Inc.ZBIO	7.30%	3,919,159	view →
2025-09-15	SCHEDULE	Camp4 Therapeutics CorpCAMP	8.10%	3,785,802	view →

Alert me when Enavate Sciences GP, LLC files anything

Free. We email you when criteria match. One-click unsubscribe in every email.

Track this filer's every move in real time.

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →